Rationale for use of non-high-density lipoprotein cholesterol rather than low-density lipoprotein cholesterol as a tool for lipoprotein cholesterol screening and assessment of risk and therapy

American Journal of Cardiology

Volumn 81, Issue 4 A, 1998, Pages 26B-31B

  Frost, Philip H ^a,b   Havel, Richard J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MEVINOLIN; NICOTINIC ACID; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

CHOLESTEROL BLOOD LEVEL; CONFERENCE PAPER; CORONARY ARTERY DISEASE; CORONARY RISK; DYSLIPOPROTEINEMIA; HEART INFARCTION; HUMAN; LIPID ANALYSIS; LIPOPROTEIN BLOOD LEVEL; PRIORITY JOURNAL; RISK ASSESSMENT; SCREENING;

EID: 0032568089     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(98)00034-4     Document Type: Conference Paper

References (18)

1. Expert Panel (Adult Treatment Panel II). Detection, evaluation, and treatment of high blood cholesterol in adults. Circulation 1994;89:1329-1445.
2. Havel RJ, Rapaport E. Management of primary hyperlipidemia. N Engl J Med 1995;332:1491-1498.
3. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499-552.
4. Hokanson JE, Austin M. Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies. J Cardiovasc Risk 1996; 3:213-219.
5. Pagnan A, Havel RJ, Kane JP, Kotite L. Characterization of human very low density lipoproteins containing two electrophoretic populations: double pre-beta lipoproteinemia and primary dysbetalipoproteinemia. J Lipid Res 1977;18:613-622.
6. Havel RJ. McCollum Award Lecture, 1993: triglyceride-rich lipoproteins and atherosclerosis - new perspectives. Am J Clin Nutr 1994;59:795-799.
7. Havel RJ. Postprandial hyperlipidemia and remnant lipoproteins. Curr Opin Lipidol 1994;5:102-109.
8. Bradley WA, Gianturco SH. Triglyceride-rich lipoproteins and atherosclerosis: pathophysiological considerations. J Intern Med 1994;736:33-39.
9. Hamsten A. Hypertriglyceridemia, triglyceride-rich lipoproteins and coronary heart disease. Balliere's Clin Endocrinol Metab 1990;4:895-922.
10. Rubiés-Prat J, Reverter JL, Senti M, Pedro-Botet J, Salinas I, Lucas A, Nogues X, Sanmarti A. Calculated low-density lipoprotein cholesterol should not be used for management of lipoprotein abnormalities in patients with diabetes mellitus. Diabetes Care 1993;16:1081-1086.
11. Senti M, Pedro-Botet J, Nogues X, Rubiés-Prat J. Influence of intermediate-density lipoproteins on the accuracy of the Friedewald formula. Clin Chem 1991;37:1394-1397.
12. Phillips NR, Waters D, Havel RJ. Plasma lipoproteins and progression of coronary artery disease evaluated by angiography and clinical events. Circulation 1993;88:2762-2770.
13. Frost PH, Davis BR, Burlando AJ, Curb JD, Guthrie GP, Isaacsohn JL, Wassertheil-Smoller S, Wilson AC, Stamler J, for SHEP Research Group. Serum lipids and incidence of coronary heart disease: findings from the Systolic Hypertension in the Elderly Program (SHEP). Circulation 1996;94: 2381-2388.
14. Vega GL, Grundy SM. Does measurement of apolipoprotein B have a place in cholesterol management? Arteriosclerosis 1990;10:668-671.
15. Illingworth DR, Stein EA, Mitchel YB, Dujovne CA, Frost PH, Knopp RH, Tun P, Zupkis RV, Greguski RA. Comparative effects of lovastatin and niacin in primary hypercholesterolemia: a prospective trial. Arch Intern Med 1994;154: 1586-1595.
16. Breslow JL. Cardiovascular disease burden increases, NIH funding decreases. Nature Med 1997;3:600-601.
17. Garg A, Grundy SM. Management of dyslipidemia in NIDDM. Diabetes Care 1990;13:153-169.
18. Havel RJ. Pathogenesis, differentiation and management of hypertriglyceridemia. Adv Intern Med 1969;5:117-154.